Background: Gamma-knife surgery (GKS) is ineffective for high-flow arteriovenous fistula (AVF). The purpose of this study was to present the angioarchitecture of the AVF of brain arteriovenous malformation (BAVM) and report our experience of endovascular embolization of AVF component prior to GKS. Methods: In the past 10 years, a total of 523 BAVMs had been treated primarily by GKS. Among these, 10 patients with AVF components were identified and referred for embolization prior to GKS. Those patients underwent GKS within 4 weeks after embolization. We analyzed retrospectively the angioarchitecture of the AVFs of BAVMs, selection of embolic materials for embolization, and treatment outcomes. Results: The location of the AVFs was anterior (n ¼ 7) or middle (n ¼ 3) cerebral artery. Central and peripheral types of AVFs were found in seven and three patients, respectively. Nine AVFs were totally occluded by a single session of endovascular embolization, while one failed to be embolized because it was inaccessible to a microcatheter. Detachable coils (n ¼ 6) or combination of liquid adhesives (n ¼ 3) were selected to embolize the AVF. No significant periprocedural neurological complication was found. BAVMs were obliterated totally by subsequent GKS in six patients and partial occlusion was achieved in one, while three still awaited the effect of GKS. Mean imaging and clinical follow-up periods were 35 and 48 months, respectively. Conclusion: Early detection of the central type of AVF of BAVM prior to GKS may be difficult because of its overlapping with feeder, nidus, and/or venous drains or it being overlooked. Peripheral-type AVFs were usually evident prior to GKS, particularly those with proximal dilated venous drains. Endovascular embolization is an effective modality for managing these AVFs, which may be treated by GKS ineffectively.
Introduction
Gamma-knife surgery (GKS) is an effective modality for treatment of brain arteriovenous malformations (BAVMs). The cure rate for BAVM at 2 years after GKS may be up to 80e85% in some selected patients. 1e4 However, GKS is ineffective for high-flow arteriovenous fistula (AVF) of the BAVM. 5 Therefore, early identification and embolization of the fistula component are essential to enhance the cure rate of GKS for BAVM. In the past, the main role of embolization was to target the weak points of BAVMs such as flow-related or intra-nidus aneurysm or to reduce the size of large BAVMs, to make the BAVM amenable to subsequent GKS and minimize the risks during the latency. 4, 6, 7 Early identification and embolization of the AVF of BAVM prior to GKS have not been well evaluated.
The purpose of this study was to report our experiences of early neuroimaging identification, angioarchitecture analysis, and endovascular embolization of the AVFs of BAVMs prior to GKS.
Methods
From August 2002 to July 2011, a series of 523 patients with BAVMs were treated primarily by GKS in our hospital (Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.). Prior to GKS, all patients underwent brain magnetic resonance imaging/angiography (MRI/MRA), and cerebral digital subtraction angiography (DSA) for an analysis of the angioarchitecture and cerebral blood-flow hemodynamics. Of these patients, 10 were referred to our institute for evaluation of the feasibility of endovascular embolization because the fistula components were obvious, of high-flow, and presumed ineffective for GKS. That does not reflect the true incidence of the fistula component in BAVM in our cohort. Patient 5 had BAVM and had received GKS 3 years earlier, with a residual BAVM. Prior to the initiation of this study, informed consent was obtained from all 10 patients. All these AVFs were assumed to be high-flow shunts because of larger feeders and dilated proximal venous drains with various degrees of steal phenomenon depicted by DSA. We graded the BAVM according to the SpetzlereMartin proposal; in addition, the AVF was classified as central or peripheral type based on whether the fistula was located within or adjacent to the nidus of the BAVM. The participants included six men and four women, aged 6e56 years (mean: 37 years), who presented with headache (n ¼ 8), seizure (n ¼ 5), dizziness (n ¼ 2), neurologic deficit because of venous infarction (n ¼ 2), or hemorrhage (n ¼ 3).
Endovascular embolization of the AVF component of BAVMs was performed using a transfemoral artery approach under general anesthesia. Systemic heparinization was achieved by administering an intravenous bolus of heparin (3000 IU) and maintained by a continuous intravenous infusion of heparin (1500 IU/h). Activated clotting time was measured every half hour during the procedure and maintained at a value that was about twice the baseline value. A 6-F guiding catheter was positioned in the internal carotid artery. Then, a wire-guiding microcatheter (SL-10; Boston Scientific Corporation, Fremont, CA, USA) was introduced and navigated to pass through the fistula coaxially. After the position of the microcatheter tip was wedged in the fistula component, detachable coils (Boston Scientifics, Fremont, CA, USA, or Microvention, Aliso Viejo, CA, USA) were introduced in nine patients through the microcatheter into the distal parent artery to the fistula and the proximal venous pouch. In three patients with larger proximal venous pouch with subtotal occlusion of the fistulas by coil depositions, a mixture of 50% N-butylcynoacrylate (NBCA; Nycomed, Ingenor, Paris, France) and Lipiodol Ultra-Fluide (Laboratoire Guerbet, France) (about 0.4e0.8 mL) was infused into the AVFs through the microcatheter. The injection of the NBCA was preceded by the administration of 5% dextrose.
A postembolization DSA was performed immediately after the completion of the procedure to check for occlusion of the fistula. All patients underwent GKS within 4 weeks after embolization. All patients received clinical and/or MRI follow-up (mean: 48 and 35 months, respectively). To follow the progression of BAVMs (mean: 39 months), DSA was performed in nine patients.
Results
The clinical findings and treatment outcomes of 10 patients are summarized in Table 1 . Six BAVMs were of Grade 3, Table 1 Demographic and clinical outcomes in 10 patients with AVF components of BAVMs after embolization and GKS. based on the SpetzlereMartin proposal 8 ; Grade 2 or 4 was found in two patients in each group. The location of the AVFs was anterior (n ¼ 7, Figs. 1 and 2) or middle (n ¼ 3) cerebral artery. Regarding venous drains of AVF/BAVM, single superficial venous drains were found in three patients, multiple superficial venous drains were found in four patients, and multiple superficial and deep venous drains were found in three patients. Detachable coils were selected to occlude the fistula in six patients (Fig. 2) and combinations of detachable coils and liquid adhesives were used in three patients (Fig. 1) . Complete fistula occlusion was achieved in nine patients with AVFs in a single session of embolization (Figs. 1 and 2) . In one patient, we failed to access and embolize peripheral AVF because of the markedly tortuous feeder of the anterior choroid artery; subsequently, the patient underwent GKS alone. No significant procedure-related neurological complication such as intracranial hemorrhage or infarction was observed in nine patients undergoing embolization. Follow-up DSA was performed in seven of nine patients undergoing embolization, which demonstrated no evidence of fistula recurrence. The MRI and/or DSA outcomes of BAVMs after GKS were total obliteration in six patients, still awaiting the effect of GKS in three patients (follow-up less than 24 months), and residual BAVMs in one. Complete (n ¼ 6) and partial regression (n ¼ 2) of the symptoms were found in eight patients, while two patients remained stable with medication.
Discussion
GKS, which is a less invasive modality for managing BAVM, shows promising results. However, it fails to cure about 20e30% of patients.
9,10 The 3-year follow-up DSA showed several factors related to the failure of GKS for BAVMs. These included inadequate nidus definition, large nidus volume, suboptimal radiation dose, and radio resistance because of high-flow AVF component. 1e5, 9, 10 AVF is a direct shunt between an arterial feeder and its venous drain without intervening arteriovenous nidus. The fistula can be categorized as a low-or a high-flow shunt depending on the size of the shunt and the steal phenomenon. In a high-flow AVF, it is usually a single fistula with a large shunt having a short and direct route, and the blood flow is high and rapid, with a moderate to severe steal phenomenon because of the large pressure gradient between the artery and the venous system. Sequelae of intracranial AVFs include an arterial steal phenomenon with cerebral hypoperfusion and an increased flow in cerebral veins resulting in intracranial venous congestion, ischemic change, or hemorrhage. Because the majority of high-flow AVFs are supplied by larger feeders with relatively short and directed routes, endovascular embolization is an effective and safe modality to manage these AVFs, with promising outcomes.
5,11
The BAVM associated with AVF is not uncommon. The existence of a high-flow AVF was reported to cause failure of GKS treatment in 5.8% of patients with BAVMs. 9 Therefore, early identification and embolization of the fistula component of BAVM prior to GKS are essential to enhance the success rate of complete obliteration of the BAVM. In this study we classified the BAVM-associated high-flow AVF into two types, central and peripheral. Central type of AVF is more common and usually mixes with nidus part of the BAVM. These fistulas are usually difficult to detect by neuroimaging prior to GKS because of their superimposition with feeders, nidus, or venous drains. However, if DSA demonstrated an enlarged venous pouch in the nidus part with earlier contrast opacification than other venous drains, the central type of AVF should be suspected. On the contrary, the peripheral type of AVF located on the periphery of the BAVM nidus can usually be clearly detected by its larger feeders with dilated venous drains. Occasionally, the peripheral type of fistula component of the BAVM may be confused with a coexistence of isolated cerebral AVF. An isolated cerebral AVF is usually located in a different arterial territory and has its own venous drain prior to draining into the dural sinus. By contrast, the peripheral type of AVF of the BAVM has common venous outflow drains with the nidus part.
With regard to the imaging evaluation of angioarchitecture of the BAVM, MRI/MRA is a good and noninvasive tool without radiation for pre-GKS to evaluate the morphology of the BAVM and demonstrate its relationship with nearby brain tissue. Furthermore, it is a very useful modality to monitor the progression of the BAVMs and the presence of any adverse radiation effects after GKS. However, the major concerns about MRA are its incapacity/inability to demonstrate cerebral blood-flow hemodynamics and that it may have difficulties in illustrating the real size of the nidus component and the presence of the AVF component of the BAVM. Conventional global cerebral DSA is the current reference and gold standard for the diagnosis, assessment, and management of BAVMs. However, in the absence of superselective microcatheterization and injection, a precise definition of nidus angioarchitecture including the fistula component is almost impossible because it may overlap with feeder, nidus, and venous drains, particularly those of central types. To search for the associated AVF and enhance the success rate of subsequent GKS for the treatment of BAVMs, Pollock et al 10 have applied microcatheter superselective angiography (MSA) as a part of pretherapeutic evaluation. MSA can clarify and delineate AVF within the nidus. The second advantage of MSA is that it may allow the immediate treatment of AVF with an acceptable low risk of morbidity and mortality, and reduce the risk of neurologic deficit or hemorrhage during the latency after GKS. However, the disadvantages of MSA are that it is time consuming and the use of a microcatheter to search for the potential AVF is too expensive if embolization is not initiated. In addition, it may increase procedural risks such as those of an thromboembolic event or an arterial injury. In our study, only 10 out of 523 patients (1.9%) with AVF components were identified early and referred for embolization. This low rate of identification of fistula components likely reflects the overlooking of the AVF, ignoring of its superimposition onto feeder/nidus/venous drains, or lack of MSA to search for its presence. Theoretically, the AVF part may become obvious once the majority of nidus is obliterated by GKS.
At the present time, most embolizations of BAVMs have been conducted prior to GKS, with many positive effects and promising results. However, pre-GKS embolization might itself be a negative predictor for patient outcome. In a multivariate analysis of 19 incomplete obliterations after BAVM GKS, three (16%) had recanalization of a portion of the BAVM after embolization 12e14 ; therefore, repeat GKS was required. Previously embolized BAVMs may also make dose planning more difficult if the resultant shape of the BAVM is irregular or has been divided into multiple compartments. Furthermore, embolization carries inherent periprocedural risks, such as intracranial hemorrhage or ischemic stroke. Recognition of the limitations and risks of embolization as an adjunct to pre-GKS has led our team to decide to treat AVFs only. The nidus parts of the BAVM are usually ignored and managed by subsequent GKS.
As to the selection of the microcatheter and embolic agent, it largely depends on the fistula anatomy and flow characteristics. If the high-flow fistulas are fed by a short and directed parent artery and can be accessed by a wire-guided microcatheter from arterial to venous sites, we prefer to select detachable coils for occluding the AVF, because the procedure can be controlled easily and coils can be deposited precisely into the venous sac, fistula, and its proximal parent artery, leading to total occlusion of the fistula. 11 In our study, to enhance the effect of fistula occlusion and to decrease the number of coils and cost, variable amounts of NBCA mixtures were infused into the residual fistula after subtotal fistula occlusion in four AVFs. In this study, we did not select NBCA or Onyx alone as an embolizer, largely because they are liquid embolic agents. It is difficult to control their flow and deposition after injection. In addition, embolization of high-flow fistula by selection of liquid embolic agents may have the risk of distal migration of embolizer to venous drains, leading to catastrophic complications such as venous infarction or nidus rupture because of occlusion of the outlet, particularly when the AVF/BAVM have only single venous drains.
In conclusion, BAVM associated with a high-flow AVF may be found occasionally prior to GKS. It can be of central or peripheral type. Early identification of the central type may be difficult by conventional neuroimages due to its superimposition with nidus, feeder, and/or venous drains or it being overlooked. On the contrary, the majority of peripheral AVFs usually are evident prior to GKS. Endovascular embolization is feasible and effective in managing these high-flow fistulas, and may enhance the successful cure rate of subsequent GKS.
